Cancer cells often exhibit elevated levels of ROS compared to normal cells, which can promote tumorigenesis by causing DNA damage, stimulating cell proliferation, and inhibiting apoptosis. However, excessive ROS can also be detrimental to cancer cells. This paradoxical role makes pro-oxidants both a potential risk factor and a therapeutic target in cancer.
